世界の心膜炎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pericarditis Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4680 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、心膜炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬（NSAID）、コルヒチン、ステロイド、抗生物質、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・心膜炎治療薬の市場動向 ・企業の競争状況、市場シェア ・心膜炎治療薬の種類別市場規模と予測2016-2027（非ステロイド性抗炎症薬（NSAID）、コルヒチン、ステロイド、抗生物質、その他） ・心膜炎治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・心膜炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・心膜炎治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・心膜炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心膜炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・心膜炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer Inc、Sanofi、Novartis、Bayer、AstraZeneca、Takeda Pharmaceuticals Industries Ltd、Teva Pharmaceutical Industries Ltd、Merck & Co., Inc、Abbive(Allergan)、Hikma Pharmaceuticals PLC、Avion Pharmaceuticals LLC、Dr. Reddy’s Laboratories Ltd、Viatris、Amneal Pharmaceuticals LLC、Sun Pharmaceuticals Industries Ltd、Lupin） ・結論

Pericarditis is the inflammation of the pericardium. Pericardium is two thin layers of a sac like structure of tissues that surrounds the heart. The pericardium holds the heart in place and helps it work. It is a small amount of fluid that keeps both the layers separated from each other so that there is no friction between the layers. Pericarditis often causes chest pain and other symptoms too. The harsh chest pain associated with pericardium occurs when the layers of the pericardium rub against each other. Pericarditis usually begins suddenly but does not last for long.When symptoms related to pericarditis develops more gradually or persists, it is considered as chronic pericarditis. Most cases of pericarditis are mild and usually improve on their own. The common symptoms related to pericarditis include cough; leg or abdominal swelling; low-grade fever; heart palpitations; shortness of breath when reclining; an overall sense of weakness, feeling sick or fatigue; and sharp, piercing chest pain. Pericarditis can be diagnosed with the help of electrocardiogram results, echocardiogram, physical examination, cardiac MRI, and reported symptoms.

Market Analysis and Insights: Global Pericarditis Drugs Market
The global Pericarditis Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pericarditis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pericarditis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pericarditis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pericarditis Drugs market.

Global Pericarditis Drugs Scope and Market Size
Pericarditis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pericarditis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
By Drug
Nonsteroidal Anti-Inflammatory Agents (NSAIDs)
Colchicine
Steroids
Antibiotics
Others
By Route of Administration
Intravenous
Oral
Others
By Disease
Acute Pericarditis
Chronic Pericarditis
Recurrent Pericarditis
Idiopathic Pericarditis

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer Inc
Sanofi
Novartis
Bayer
AstraZeneca
Takeda Pharmaceuticals Industries Ltd
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Abbive(Allergan)
Hikma Pharmaceuticals PLC
Avion Pharmaceuticals LLC
Dr. Reddy’s Laboratories Ltd
Viatris
Amneal Pharmaceuticals LLC
Sun Pharmaceuticals Industries Ltd
Lupin

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pericarditis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nonsteroidal Anti-Inflammatory Agents (NSAIDs)
1.2.3 Colchicine
1.2.4 Steroids
1.2.5 Antibiotics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pericarditis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pericarditis Drugs Market Perspective (2016-2027)
2.2 Pericarditis Drugs Growth Trends by Regions
2.2.1 Pericarditis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pericarditis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Pericarditis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Pericarditis Drugs Industry Dynamic
2.3.1 Pericarditis Drugs Market Trends
2.3.2 Pericarditis Drugs Market Drivers
2.3.3 Pericarditis Drugs Market Challenges
2.3.4 Pericarditis Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pericarditis Drugs Players by Revenue
3.1.1 Global Top Pericarditis Drugs Players by Revenue (2016-2021)
3.1.2 Global Pericarditis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Pericarditis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pericarditis Drugs Revenue
3.4 Global Pericarditis Drugs Market Concentration Ratio
3.4.1 Global Pericarditis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pericarditis Drugs Revenue in 2020
3.5 Pericarditis Drugs Key Players Head office and Area Served
3.6 Key Players Pericarditis Drugs Product Solution and Service
3.7 Date of Enter into Pericarditis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pericarditis Drugs Breakdown Data by Type
4.1 Global Pericarditis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Pericarditis Drugs Forecasted Market Size by Type (2022-2027)

5 Pericarditis Drugs Breakdown Data by Application
5.1 Global Pericarditis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Pericarditis Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pericarditis Drugs Market Size (2016-2027)
6.2 North America Pericarditis Drugs Market Size by Type
6.2.1 North America Pericarditis Drugs Market Size by Type (2016-2021)
6.2.2 North America Pericarditis Drugs Market Size by Type (2022-2027)
6.2.3 North America Pericarditis Drugs Market Size by Type (2016-2027)
6.3 North America Pericarditis Drugs Market Size by Application
6.3.1 North America Pericarditis Drugs Market Size by Application (2016-2021)
6.3.2 North America Pericarditis Drugs Market Size by Application (2022-2027)
6.3.3 North America Pericarditis Drugs Market Size by Application (2016-2027)
6.4 North America Pericarditis Drugs Market Size by Country
6.4.1 North America Pericarditis Drugs Market Size by Country (2016-2021)
6.4.2 North America Pericarditis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pericarditis Drugs Market Size (2016-2027)
7.2 Europe Pericarditis Drugs Market Size by Type
7.2.1 Europe Pericarditis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Pericarditis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Pericarditis Drugs Market Size by Type (2016-2027)
7.3 Europe Pericarditis Drugs Market Size by Application
7.3.1 Europe Pericarditis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Pericarditis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Pericarditis Drugs Market Size by Application (2016-2027)
7.4 Europe Pericarditis Drugs Market Size by Country
7.4.1 Europe Pericarditis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Pericarditis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pericarditis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Pericarditis Drugs Market Size by Type
8.2.1 Asia-Pacific Pericarditis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pericarditis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pericarditis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Pericarditis Drugs Market Size by Application
8.3.1 Asia-Pacific Pericarditis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pericarditis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pericarditis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Pericarditis Drugs Market Size by Region
8.4.1 Asia-Pacific Pericarditis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pericarditis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pericarditis Drugs Market Size (2016-2027)
9.2 Latin America Pericarditis Drugs Market Size by Type
9.2.1 Latin America Pericarditis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Pericarditis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Pericarditis Drugs Market Size by Type (2016-2027)
9.3 Latin America Pericarditis Drugs Market Size by Application
9.3.1 Latin America Pericarditis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Pericarditis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Pericarditis Drugs Market Size by Application (2016-2027)
9.4 Latin America Pericarditis Drugs Market Size by Country
9.4.1 Latin America Pericarditis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Pericarditis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pericarditis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Pericarditis Drugs Market Size by Type
10.2.1 Middle East & Africa Pericarditis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pericarditis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pericarditis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Pericarditis Drugs Market Size by Application
10.3.1 Middle East & Africa Pericarditis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pericarditis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pericarditis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Pericarditis Drugs Market Size by Country
10.4.1 Middle East & Africa Pericarditis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pericarditis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Details
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Pericarditis Drugs Introduction
11.1.4 Pfizer Inc Revenue in Pericarditis Drugs Business (2016-2021)
11.1.5 Pfizer Inc Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Pericarditis Drugs Introduction
11.2.4 Sanofi Revenue in Pericarditis Drugs Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Pericarditis Drugs Introduction
11.3.4 Novartis Revenue in Pericarditis Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Pericarditis Drugs Introduction
11.4.4 Bayer Revenue in Pericarditis Drugs Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Pericarditis Drugs Introduction
11.5.4 AstraZeneca Revenue in Pericarditis Drugs Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Takeda Pharmaceuticals Industries Ltd
11.6.1 Takeda Pharmaceuticals Industries Ltd Company Details
11.6.2 Takeda Pharmaceuticals Industries Ltd Business Overview
11.6.3 Takeda Pharmaceuticals Industries Ltd Pericarditis Drugs Introduction
11.6.4 Takeda Pharmaceuticals Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021)
11.6.5 Takeda Pharmaceuticals Industries Ltd Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Details
11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Pericarditis Drugs Introduction
11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 Merck & Co., Inc
11.8.1 Merck & Co., Inc Company Details
11.8.2 Merck & Co., Inc Business Overview
11.8.3 Merck & Co., Inc Pericarditis Drugs Introduction
11.8.4 Merck & Co., Inc Revenue in Pericarditis Drugs Business (2016-2021)
11.8.5 Merck & Co., Inc Recent Development
11.9 Abbive(Allergan)
11.9.1 Abbive(Allergan) Company Details
11.9.2 Abbive(Allergan) Business Overview
11.9.3 Abbive(Allergan) Pericarditis Drugs Introduction
11.9.4 Abbive(Allergan) Revenue in Pericarditis Drugs Business (2016-2021)
11.9.5 Abbive(Allergan) Recent Development
11.10 Hikma Pharmaceuticals PLC
11.10.1 Hikma Pharmaceuticals PLC Company Details
11.10.2 Hikma Pharmaceuticals PLC Business Overview
11.10.3 Hikma Pharmaceuticals PLC Pericarditis Drugs Introduction
11.10.4 Hikma Pharmaceuticals PLC Revenue in Pericarditis Drugs Business (2016-2021)
11.10.5 Hikma Pharmaceuticals PLC Recent Development
11.11 Avion Pharmaceuticals LLC
11.11.1 Avion Pharmaceuticals LLC Company Details
11.11.2 Avion Pharmaceuticals LLC Business Overview
11.11.3 Avion Pharmaceuticals LLC Pericarditis Drugs Introduction
11.11.4 Avion Pharmaceuticals LLC Revenue in Pericarditis Drugs Business (2016-2021)
11.11.5 Avion Pharmaceuticals LLC Recent Development
11.12 Dr. Reddy’s Laboratories Ltd
11.12.1 Dr. Reddy’s Laboratories Ltd Company Details
11.12.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.12.3 Dr. Reddy’s Laboratories Ltd Pericarditis Drugs Introduction
11.12.4 Dr. Reddy’s Laboratories Ltd Revenue in Pericarditis Drugs Business (2016-2021)
11.12.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.13 Viatris
11.13.1 Viatris Company Details
11.13.2 Viatris Business Overview
11.13.3 Viatris Pericarditis Drugs Introduction
11.13.4 Viatris Revenue in Pericarditis Drugs Business (2016-2021)
11.13.5 Viatris Recent Development
11.14 Amneal Pharmaceuticals LLC
11.14.1 Amneal Pharmaceuticals LLC Company Details
11.14.2 Amneal Pharmaceuticals LLC Business Overview
11.14.3 Amneal Pharmaceuticals LLC Pericarditis Drugs Introduction
11.14.4 Amneal Pharmaceuticals LLC Revenue in Pericarditis Drugs Business (2016-2021)
11.14.5 Amneal Pharmaceuticals LLC Recent Development
11.15 Sun Pharmaceuticals Industries Ltd
11.15.1 Sun Pharmaceuticals Industries Ltd Company Details
11.15.2 Sun Pharmaceuticals Industries Ltd Business Overview
11.15.3 Sun Pharmaceuticals Industries Ltd Pericarditis Drugs Introduction
11.15.4 Sun Pharmaceuticals Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021)
11.15.5 Sun Pharmaceuticals Industries Ltd Recent Development
11.16 Lupin
11.16.1 Lupin Company Details
11.16.2 Lupin Business Overview
11.16.3 Lupin Pericarditis Drugs Introduction
11.16.4 Lupin Revenue in Pericarditis Drugs Business (2016-2021)
11.16.5 Lupin Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pericarditis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nonsteroidal Anti-Inflammatory Agents (NSAIDs)
Table 3. Key Players of Colchicine
Table 4. Key Players of Steroids
Table 5. Key Players of Antibiotics
Table 6. Key Players of Others
Table 7. Global Pericarditis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pericarditis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pericarditis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Pericarditis Drugs Market Share by Regions (2016-2021)
Table 11. Global Pericarditis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Pericarditis Drugs Market Share by Regions (2022-2027)
Table 13. Pericarditis Drugs Market Trends
Table 14. Pericarditis Drugs Market Drivers
Table 15. Pericarditis Drugs Market Challenges
Table 16. Pericarditis Drugs Market Restraints
Table 17. Global Pericarditis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Pericarditis Drugs Market Share by Players (2016-2021)
Table 19. Global Top Pericarditis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pericarditis Drugs as of 2020)
Table 20. Ranking of Global Top Pericarditis Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Pericarditis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pericarditis Drugs Product Solution and Service
Table 24. Date of Enter into Pericarditis Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pericarditis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Pericarditis Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Pericarditis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Pericarditis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Pericarditis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Pericarditis Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Pericarditis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Pericarditis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Pericarditis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Pericarditis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Pericarditis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Pericarditis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Pericarditis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Pericarditis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Pericarditis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Pericarditis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Pericarditis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Pericarditis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Pericarditis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Pericarditis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pericarditis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pericarditis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pericarditis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pericarditis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pericarditis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Pericarditis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Pericarditis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Pericarditis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Pericarditis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Pericarditis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Pericarditis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Pericarditis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pericarditis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pericarditis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pericarditis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pericarditis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pericarditis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Pericarditis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Inc Company Details
Table 65. Pfizer Inc Business Overview
Table 66. Pfizer Inc Pericarditis Drugs Product
Table 67. Pfizer Inc Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 68. Pfizer Inc Recent Development
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Pericarditis Drugs Product
Table 72. Sanofi Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 73. Sanofi Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Pericarditis Drugs Product
Table 77. Novartis Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Pericarditis Drugs Product
Table 82. Bayer Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 83. Bayer Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Pericarditis Drugs Product
Table 87. AstraZeneca Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Takeda Pharmaceuticals Industries Ltd Company Details
Table 90. Takeda Pharmaceuticals Industries Ltd Business Overview
Table 91. Takeda Pharmaceuticals Industries Ltd Pericarditis Drugs Product
Table 92. Takeda Pharmaceuticals Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 93. Takeda Pharmaceuticals Industries Ltd Recent Development
Table 94. Teva Pharmaceutical Industries Ltd Company Details
Table 95. Teva Pharmaceutical Industries Ltd Business Overview
Table 96. Teva Pharmaceutical Industries Ltd Pericarditis Drugs Product
Table 97. Teva Pharmaceutical Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 98. Teva Pharmaceutical Industries Ltd Recent Development
Table 99. Merck & Co., Inc Company Details
Table 100. Merck & Co., Inc Business Overview
Table 101. Merck & Co., Inc Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 102. Merck & Co., Inc Recent Development
Table 103. Abbive(Allergan) Company Details
Table 104. Abbive(Allergan) Business Overview
Table 105. Abbive(Allergan) Pericarditis Drugs Product
Table 106. Abbive(Allergan) Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 107. Abbive(Allergan) Recent Development
Table 108. Hikma Pharmaceuticals PLC Company Details
Table 109. Hikma Pharmaceuticals PLC Business Overview
Table 110. Hikma Pharmaceuticals PLC Pericarditis Drugs Product
Table 111. Hikma Pharmaceuticals PLC Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 112. Hikma Pharmaceuticals PLC Recent Development
Table 113. Avion Pharmaceuticals LLC Company Details
Table 114. Avion Pharmaceuticals LLC Business Overview
Table 115. Avion Pharmaceuticals LLC Pericarditis Drugs Product
Table 116. Avion Pharmaceuticals LLC Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 117. Avion Pharmaceuticals LLC Recent Development
Table 118. Dr. Reddy’s Laboratories Ltd Company Details
Table 119. Dr. Reddy’s Laboratories Ltd Business Overview
Table 120. Dr. Reddy’s Laboratories Ltd Pericarditis Drugs Product
Table 121. Dr. Reddy’s Laboratories Ltd Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 122. Dr. Reddy’s Laboratories Ltd Recent Development
Table 123. Viatris Company Details
Table 124. Viatris Business Overview
Table 125. Viatris Pericarditis Drugs Product
Table 126. Viatris Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 127. Viatris Recent Development
Table 128. Amneal Pharmaceuticals LLC Company Details
Table 129. Amneal Pharmaceuticals LLC Business Overview
Table 130. Amneal Pharmaceuticals LLC Pericarditis Drugs Product
Table 131. Amneal Pharmaceuticals LLC Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 132. Amneal Pharmaceuticals LLC Recent Development
Table 133. Sun Pharmaceuticals Industries Ltd Company Details
Table 134. Sun Pharmaceuticals Industries Ltd Business Overview
Table 135. Sun Pharmaceuticals Industries Ltd Pericarditis Drugs Product
Table 136. Sun Pharmaceuticals Industries Ltd Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 137. Sun Pharmaceuticals Industries Ltd Recent Development
Table 138. Lupin Company Details
Table 139. Lupin Business Overview
Table 140. Lupin Pericarditis Drugs Product
Table 141. Lupin Revenue in Pericarditis Drugs Business (2016-2021) & (US$ Million)
Table 142. Lupin Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pericarditis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Nonsteroidal Anti-Inflammatory Agents (NSAIDs) Features
Figure 3. Colchicine Features
Figure 4. Steroids Features
Figure 5. Antibiotics Features
Figure 6. Others Features
Figure 7. Global Pericarditis Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Pericarditis Drugs Report Years Considered
Figure 12. Global Pericarditis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Pericarditis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Pericarditis Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Pericarditis Drugs Market Share by Regions (2022-2027)
Figure 16. Global Pericarditis Drugs Market Share by Players in 2020
Figure 17. Global Top Pericarditis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pericarditis Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Pericarditis Drugs Revenue in 2020
Figure 19. Global Pericarditis Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Pericarditis Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Pericarditis Drugs Market Share by Type (2016-2027)
Figure 23. North America Pericarditis Drugs Market Share by Application (2016-2027)
Figure 24. North America Pericarditis Drugs Market Share by Country (2016-2027)
Figure 25. United States Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pericarditis Drugs Market Share by Type (2016-2027)
Figure 29. Europe Pericarditis Drugs Market Share by Application (2016-2027)
Figure 30. Europe Pericarditis Drugs Market Share by Country (2016-2027)
Figure 31. Germany Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pericarditis Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Pericarditis Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Pericarditis Drugs Market Share by Region (2016-2027)
Figure 41. China Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pericarditis Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Pericarditis Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Pericarditis Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pericarditis Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Pericarditis Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Pericarditis Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Pericarditis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Inc Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 65. Takeda Pharmaceuticals Industries Ltd Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 67. Merck & Co., Inc Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 68. Abbive(Allergan) Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 69. Hikma Pharmaceuticals PLC Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 70. Avion Pharmaceuticals LLC Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 71. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 72. Viatris Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 73. Amneal Pharmaceuticals LLC Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 74. Sun Pharmaceuticals Industries Ltd Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 75. Lupin Revenue Growth Rate in Pericarditis Drugs Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

---